Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Current Availability and Prescribing Status in the UK Retatrutide is not licensed or commercially available in the UK
The pattern of investor response to cliff events has been consistent: stocks tend to price in the cliff gradually as expiry approaches, with the sharpest re-ratings occurring when the first Paragraph IV filing appears (signaling that generic entry is imminent) and when initial generic market share data appears post-launch
doi:10.1210/jcem.83.7.4877 127
Last Published 04.01.2026 Effective Date: 04.01.2026 This policy addresses the use of somatostatin analogs, including Sandostatin (octreotide acetate), Sandostatin LAR (octreotide acetate LAR), Signifor (pasireotide diaspartate), Signifor LAR (pasireotide), and Somatuline Depot (lanreotide), and Lanreotide Injection
(2025) JAMA Netw Open, 8: e2456170
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 27.18
US$ 23.37
US$ 20.18
US$ 27.25
US$ 20.72
US$ 21.88
US$ 28.42
